comparemela.com

Latest Breaking News On - Secondary primary malignancy - Page 1 : comparemela.com

Targeted Therapy Associated With Lower SPM Risk Among Treated Patients With CLL

Investigators found patients receiving chemotherapy had a greater risk of a secondary primary malignancy (SPM) compared with those treated with targeted therapies or those whose chronic lymphocytic leukemia (CLL) was left untreated.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.